Literature DB >> 11435553

OX40 stimulation by gp34/OX40 ligand enhances productive human immunodeficiency virus type 1 infection.

Y Takahashi1, Y Tanaka, A Yamashita, Y Koyanagi, M Nakamura, N Yamamoto.   

Abstract

OX40 is a member of the tumor necrosis factor (TNF) receptor superfamily and known to be an important costimulatory molecule expressed on activated T cells. To investigate the role of costimulation of OX40 in human immunodeficiency virus type 1 (HIV-1) infection by its natural ligand, gp34, the OX40-transfected ACH-2 cell line, ACH-2/OX40, chronically infected with HIV-1, was cocultured with paraformaldehyde (PFA)-fixed gp34-transfected mouse cell line, SV-T2/gp34. The results showed that HIV-1 production was strongly induced. This was followed by apparent apoptosis, and both processes were specifically inhibited by the gp34-specific neutralizing monoclonal antibody 5A8. Endogenous TNF alpha (TNF-alpha) and TNF-beta production were not involved in the enhanced HIV-1 production. Furthermore, enhanced HIV-1 transcription in gp34-stimulated ACH-2/OX40 cells was dependent on the kappa B site of the HIV-1 long terminal repeat, and the OX40-gp34 interaction activated NF-kappa B consisting of p50 and p65 subunits. When primary activated CD4(+) T cells acutely infected with HIV-1(NL4-3) (CXCR4-using T-cell-line-tropic) were cocultured with PFA-fixed gp34(+) human T-cell leukemia virus type 1-bearing MT-2 cells or SV-T2/gp34 cells, HIV-1 production was also markedly enhanced. The enhancement was again significantly inhibited by 5A8. The present study first shows that OX40-gp34 interaction stimulates HIV-1 expression and suggests that OX40 triggering by gp34 may play an important role in enhancing HIV-1 production in both acutely and latently infected CD4(+) T cells in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435553      PMCID: PMC114401          DOI: 10.1128/JVI.75.15.6748-6757.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Intracellular signaling of gp34, the OX40 ligand: induction of c-jun and c-fos mRNA expression through gp34 upon binding of its receptor, OX40.

Authors:  Y Matsumura; T Hori; S Kawamata; A Imura; T Uchiyama
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

2.  Contribution of NF-kappa B and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types.

Authors:  E K Ross; A J Buckler-White; A B Rabson; G Englund; M A Martin
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Anti-CD2 receptor antibodies activate the HIV long terminal repeat in T lymphocytes.

Authors:  P Bressler; G Pantaleo; A Demaria; A S Fauci
Journal:  J Immunol       Date:  1991-10-01       Impact factor: 5.422

4.  Cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodeficiency virus (HIV): enhancement of HIV replication.

Authors:  T Matsuyama; Y Hamamoto; G Soma; D Mizuno; N Yamamoto; N Kobayashi
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

5.  Generation and characterization of monoclonal antibodies against multiple epitopes on the C-terminal half of envelope gp46 of human T-cell leukemia virus type-I (HTLV-I).

Authors:  Y Tanaka; M Yasumoto; H Nyunoya; T Ogura; M Kikuchi; K Shimotohno; H Shiraki; N Kuroda; H Shida; H Tozawa
Journal:  Int J Cancer       Date:  1990-10-15       Impact factor: 7.396

6.  Production of a recombinant human T-cell leukemia virus type-I trans-activator (tax1) antigen and its utilization for generation of monoclonal antibodies against various epitopes on the tax1 antigen.

Authors:  Y Tanaka; A Yoshida; H Tozawa; H Shida; H Nyunoya; K Shimotohno
Journal:  Int J Cancer       Date:  1991-06-19       Impact factor: 7.396

Review 7.  Multifactorial nature of human immunodeficiency virus disease: implications for therapy.

Authors:  A S Fauci
Journal:  Science       Date:  1993-11-12       Impact factor: 47.728

8.  Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax.

Authors:  S Miura; K Ohtani; N Numata; M Niki; K Ohbo; Y Ina; T Gojobori; Y Tanaka; H Tozawa; M Nakamura
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

9.  Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms.

Authors:  G Poli; P Bressler; A Kinter; E Duh; W C Timmer; A Rabson; J S Justement; S Stanley; A S Fauci
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

10.  Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.

Authors:  Y Ishida; Y Agata; K Shibahara; T Honjo
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

View more
  9 in total

1.  Jurkat-Derived (J-Lat, J1.1, and Jurkat E4) and CEM-Derived T Cell Lines (8E5 and ACH-2) as Models of Reversible Proviral Latency.

Authors:  Anthony Rodari; Guido Poli; Carine Van Lint
Journal:  Methods Mol Biol       Date:  2022

Review 2.  OX40:OX40L axis: emerging targets for improving poxvirus-based CD8(+) T-cell vaccines against respiratory viruses.

Authors:  John Goulding; Vikas Tahiliani; Shahram Salek-Ardakani
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

3.  Effects of prostratin on Cyclin T1/P-TEFb function and the gene expression profile in primary resting CD4+ T cells.

Authors:  Tzu-Ling Sung; Andrew P Rice
Journal:  Retrovirology       Date:  2006-10-02       Impact factor: 4.602

Review 4.  TNF and TNF receptor superfamily members in HIV infection: new cellular targets for therapy?

Authors:  Amit Kumar; Wasim Abbas; Georges Herbein
Journal:  Mediators Inflamm       Date:  2013-12-19       Impact factor: 4.711

5.  Heat Shock Enhances the Expression of the Human T Cell Leukemia Virus Type-I (HTLV-I) Trans-Activator (Tax) Antigen in Human HTLV-I Infected Primary and Cultured T Cells.

Authors:  Marie Kunihiro; Hideki Fujii; Takuya Miyagi; Yoshiaki Takahashi; Reiko Tanaka; Takuya Fukushima; Aftab A Ansari; Yuetsu Tanaka
Journal:  Viruses       Date:  2016-07-11       Impact factor: 5.048

Review 6.  Targeting TNF and TNF Receptor Pathway in HIV-1 Infection: from Immune Activation to Viral Reservoirs.

Authors:  Sébastien Pasquereau; Amit Kumar; Georges Herbein
Journal:  Viruses       Date:  2017-03-30       Impact factor: 5.048

7.  The transcriptome of HIV-1 infected intestinal CD4+ T cells exposed to enteric bacteria.

Authors:  Alyson C Yoder; Kejun Guo; Stephanie M Dillon; Tzu Phang; Eric J Lee; Michael S Harper; Karen Helm; John C Kappes; Christina Ochsenbauer; Martin D McCarter; Cara C Wilson; Mario L Santiago
Journal:  PLoS Pathog       Date:  2017-02-27       Impact factor: 6.823

8.  Robust Enhancement of Lentivirus Production by Promoter Activation.

Authors:  Naoto Suzuki; Takeshi Yoshida; Hiroaki Takeuchi; Ryuta Sakuma; Sayaka Sukegawa; Shoji Yamaoka
Journal:  Sci Rep       Date:  2018-10-11       Impact factor: 4.379

9.  Natural OX40L expressed on human T cell leukemia virus type-I-immortalized T cell lines interferes with infection of activated peripheral blood mononuclear cells by CCR5-utilizing human immunodeficiency virus.

Authors:  Daigo Kasahara; Azusa Takara; Yoshiaki Takahashi; Akira Kodama; Reiko Tanaka; Aftab A Ansari; Yuetsu Tanaka
Journal:  Virol J       Date:  2013-11-18       Impact factor: 4.099

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.